Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the ...

Jim Lacamp, Morgan Stanley Wealth Management senior vice president, joins CNBC's 'Money Movers' to discuss his outlook on the ...

Morgan Stanley’s stock (NYSE: MS) gained over 30% year-to-date. This compares to rival Goldman Sachs stock, which has seen ...

In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...

Morgan Stanley maintains a solid balance sheet, with assets reaching $1.26t and shareholder equity rising to $103.6b. Read ...

Turkey has initiated an antidumping investigation into the imports of certain steel products from China and South Korea. The ...

Despite Zinka Logistics strengths, Morgan Stanley is cautious about the stock’s valuation following its recent 105 percent run-up.

Morgan Stanley has teamed up with cross-border money transmitter Wise to settle foreign-exchange payments for the investment ...

Read here for the advantages and risks of Morgan Stanley's Series A preferred shares vs. CoCos, with insights on market ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Morgan Stanley. Looking at options history for Morgan Stanley MS we detected 18 trades. If we consider the specifics of ...

The acquisition of the oncology platform Karkinos Healthcare by Reliance Industries Limited has added another stack to the Indian conglomerate’s diagnostic and digital healthcare ecosystem, asserted ...